Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

Ann Rheum Dis. 2011 Feb;70(2):390-2. doi: 10.1136/ard.2010.129403. Epub 2010 Jul 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Female
  • Humans
  • Interleukin-1 / antagonists & inhibitors
  • Male
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Still's Disease, Adult-Onset / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Interleukin-1
  • Receptors, Interleukin-6
  • Tumor Necrosis Factor-alpha
  • tocilizumab